In this interview we discuss the CRISPR technology currently being used to “edit” genes and when we might see the technology in mainstream practice.
Ji Luo, PhD
Advertisement
Articles by Ji Luo, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC
2
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
3
Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial
4
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
5